{"id":"https://openalex.org/W4289522083","doi":"https://doi.org/10.34067/kid.0001562022","title":"Safety and Efficacy of Patiromer in Hyperkalemic Patients with CKD: A Pooled Analysis of Three Randomized Trials","display_name":"Safety and Efficacy of Patiromer in Hyperkalemic Patients with CKD: A Pooled Analysis of Three Randomized Trials","publication_year":2022,"publication_date":"2022-08-02","ids":{"openalex":"https://openalex.org/W4289522083","doi":"https://doi.org/10.34067/kid.0001562022","pmid":"https://pubmed.ncbi.nlm.nih.gov/36591361","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9802546"},"language":"en","primary_location":{"id":"doi:10.34067/kid.0001562022","doi":"https://doi.org/10.34067/kid.0001562022","is_oa":true,"landing_page_url":"https://doi.org/10.34067/kid.0001562022","pdf_url":null,"source":{"id":"https://openalex.org/S4210217782","display_name":"Kidney360","issn_l":"2641-7650","issn":["2641-7650"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","oarl","poland-20","russia-white-list-4","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Kidney360","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.34067/kid.0001562022","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110143117","display_name":"Hermann G. Haller","orcid":"https://orcid.org/0000-0002-8361-6446","observed_orcids":["https://orcid.org/0000-0002-8361-6446","https://orcid.org/0009-0000-5740-838X"]},"institutions":[{"id":"https://openalex.org/I34809795","display_name":"Medizinische Hochschule Hannover","ror":"https://ror.org/00f2yqf98","country_code":"DE","type":"education","lineage":["https://openalex.org/I34809795"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Hermann Haller","raw_affiliation_strings":["Department of Nephrology and Hypertension, Hannover Medical School, Hanover, Germany"],"raw_orcid":"https://orcid.org/0000-0002-8361-6446","affiliations":[{"raw_affiliation_string":"Department of Nephrology and Hypertension, Hannover Medical School, Hanover, Germany","institution_ids":["https://openalex.org/I34809795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052221210","display_name":"Stefano Bianchi","orcid":"https://orcid.org/0000-0003-3981-6325","observed_orcids":["https://orcid.org/0000-0003-3981-6325"]},"institutions":[{"id":"https://openalex.org/I4210149390","display_name":"Ospedale di Livorno","ror":"https://ror.org/04yrw5x43","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210149390"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Stefano Bianchi","raw_affiliation_strings":["Department of Internal Medicine, Nephrology and Dialysis Complex Operative Unit, Livorno, Italy"],"raw_orcid":"https://orcid.org/0000-0003-3981-6325","affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Nephrology and Dialysis Complex Operative Unit, Livorno, Italy","institution_ids":["https://openalex.org/I4210149390"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027355791","display_name":"Kieran McCafferty","orcid":"https://orcid.org/0000-0002-0762-2270","observed_orcids":["https://orcid.org/0000-0002-0762-2270"]},"institutions":[{"id":"https://openalex.org/I225661044","display_name":"Barts Health NHS Trust","ror":"https://ror.org/00b31g692","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I225661044"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Kieran McCafferty","raw_affiliation_strings":["Department of Nephrology, Barts Health NHS Trust, London, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0002-0762-2270","affiliations":[{"raw_affiliation_string":"Department of Nephrology, Barts Health NHS Trust, London, United Kingdom","institution_ids":["https://openalex.org/I225661044"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029919453","display_name":"Susan P. Arthur","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210167289","display_name":"Vifor Pharma (United States)","ror":"https://ror.org/05rajhp84","country_code":"US","type":"company","lineage":["https://openalex.org/I4210102083","https://openalex.org/I4210167289"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan Arthur","raw_affiliation_strings":["Biostatistics, Vifor Pharma Group, Redwood City, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biostatistics, Vifor Pharma Group, Redwood City, California","institution_ids":["https://openalex.org/I4210167289"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038312264","display_name":"Carol Moreno Quinn","orcid":"https://orcid.org/0000-0003-2741-3991","observed_orcids":["https://orcid.org/0000-0003-2741-3991"]},"institutions":[{"id":"https://openalex.org/I4210102083","display_name":"Vifor Pharma (Switzerland)","ror":"https://ror.org/0185z7g17","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210102083"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Carol Moreno Quinn","raw_affiliation_strings":["Medical Affairs, Vifor Pharma Group, Glattbrugg, Switzerland"],"raw_orcid":"https://orcid.org/0000-0003-2741-3991","affiliations":[{"raw_affiliation_string":"Medical Affairs, Vifor Pharma Group, Glattbrugg, Switzerland","institution_ids":["https://openalex.org/I4210102083"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112855918","display_name":"Jeffery Budden","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210167289","display_name":"Vifor Pharma (United States)","ror":"https://ror.org/05rajhp84","country_code":"US","type":"company","lineage":["https://openalex.org/I4210102083","https://openalex.org/I4210167289"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffery Budden","raw_affiliation_strings":["Medical Affairs, Vifor Pharma Group, Redwood City, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Affairs, Vifor Pharma Group, Redwood City, California","institution_ids":["https://openalex.org/I4210167289"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033996338","display_name":"Matthew R. Weir","orcid":"https://orcid.org/0000-0001-8820-5702","observed_orcids":["https://orcid.org/0000-0001-8820-5702"]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew R. Weir","raw_affiliation_strings":["Division of Nephrology, University of Maryland School of Medicine, Baltimore, Maryland"],"raw_orcid":"https://orcid.org/0000-0001-8820-5702","affiliations":[{"raw_affiliation_string":"Division of Nephrology, University of Maryland School of Medicine, Baltimore, Maryland","institution_ids":["https://openalex.org/I126744593"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5110143117"],"corresponding_institution_ids":["https://openalex.org/I34809795"],"apc_list":null,"apc_paid":null,"fwci":1.1284,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.77730146,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":96,"max":97},"biblio":{"volume":"3","issue":"12","first_page":"2019","last_page":"2026"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12876","display_name":"Potassium and Related Disorders","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12876","display_name":"Potassium and Related Disorders","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10516","display_name":"Parathyroid Disorders and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10291","display_name":"Dialysis and Renal Disease Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/patiromer","display_name":"patiromer","score":0.9850000143051147},{"id":"https://openalex.org/keywords/hyperkalemia","display_name":"hyperkalemia","score":0.9959999918937683},{"id":"https://openalex.org/keywords/chronic-kidney-disease","display_name":"chronic kidney disease","score":0.996999979019165},{"id":"https://openalex.org/keywords/renin-angiotensin-aldosterone-system-inhibitors","display_name":"renin-angiotensin-aldosterone system inhibitors","score":0.9449999928474426},{"id":"https://openalex.org/keywords/serum-potassium-reduction","display_name":"serum potassium reduction","score":0.7799999713897705},{"id":"https://openalex.org/keywords/end-stage-renal-disease","display_name":"end-stage renal disease","score":0.7020000219345093},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6729999780654907},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.4650000035762787},{"id":"https://openalex.org/keywords/tourmaline","display_name":"tourmaline","score":0.9750000238418579},{"id":"https://openalex.org/keywords/subgroup-analysis","display_name":"subgroup analysis","score":0.42100000381469727},{"id":"https://openalex.org/keywords/pooled-analysis-of-trials","display_name":"pooled analysis of trials","score":0.4390000104904175},{"id":"https://openalex.org/keywords/nephrotoxicity","display_name":"nephrotoxicity","score":0.5220000147819519}],"concepts":[{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.6937720775604248},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6390359401702881},{"id":"https://openalex.org/C3017906399","wikidata":"https://www.wikidata.org/wiki/Q48973845","display_name":"Pooled analysis","level":3,"score":0.5272252559661865},{"id":"https://openalex.org/C2780243291","wikidata":"https://www.wikidata.org/wiki/Q605259","display_name":"Hyperkalemia","level":2,"score":0.46507975459098816},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3116234540939331},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.3115072548389435}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006947","descriptor_name":"Hyperkalemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006947","descriptor_name":"Hyperkalemia","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011108","descriptor_name":"Polymers","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011188","descriptor_name":"Potassium","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051436","descriptor_name":"Renal Insufficiency, Chronic","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D051436","descriptor_name":"Renal Insufficiency, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.34067/kid.0001562022","doi":"https://doi.org/10.34067/kid.0001562022","is_oa":true,"landing_page_url":"https://doi.org/10.34067/kid.0001562022","pdf_url":null,"source":{"id":"https://openalex.org/S4210217782","display_name":"Kidney360","issn_l":"2641-7650","issn":["2641-7650"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","oarl","poland-20","russia-white-list-4","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Kidney360","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9802546","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9802546","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Kidney360","raw_type":"Text"},{"id":"pmid:36591361","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36591361","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Kidney360","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.34067/kid.0001562022","doi":"https://doi.org/10.34067/kid.0001562022","is_oa":true,"landing_page_url":"https://doi.org/10.34067/kid.0001562022","pdf_url":null,"source":{"id":"https://openalex.org/S4210217782","display_name":"Kidney360","issn_l":"2641-7650","issn":["2641-7650"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","medline","oarl","poland-20","russia-white-list-4","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Kidney360","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2253357373","display_name":null,"funder_award_id":"MGD&U0002","funder_id":"https://openalex.org/F4320315977","funder_display_name":"Barts Charity"}],"funders":[{"id":"https://openalex.org/F4320315977","display_name":"Barts Charity","ror":"https://ror.org/0513pp416"},{"id":"https://openalex.org/F4320323906","display_name":"Vifor Pharma","ror":"https://ror.org/0185z7g17"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W1756552807","https://openalex.org/W1970939567","https://openalex.org/W2003670762","https://openalex.org/W2056976690","https://openalex.org/W2059346848","https://openalex.org/W2063210769","https://openalex.org/W2138670606","https://openalex.org/W2149305062","https://openalex.org/W2152271789","https://openalex.org/W2182000067","https://openalex.org/W2312400976","https://openalex.org/W2324948948","https://openalex.org/W2424539745","https://openalex.org/W2475297218","https://openalex.org/W2539964972","https://openalex.org/W2764179054","https://openalex.org/W2790169725","https://openalex.org/W2809176080","https://openalex.org/W2898125318","https://openalex.org/W2898908721","https://openalex.org/W2916456221","https://openalex.org/W2972966903","https://openalex.org/W2993665959","https://openalex.org/W3005302717","https://openalex.org/W3021250193","https://openalex.org/W3028183585","https://openalex.org/W3092582090","https://openalex.org/W3101633024","https://openalex.org/W3129954143","https://openalex.org/W3132757566","https://openalex.org/W3161751710","https://openalex.org/W3201364505"],"related_works":["https://openalex.org/W2617862217","https://openalex.org/W4380626191","https://openalex.org/W2588389730","https://openalex.org/W3168617875","https://openalex.org/W1756552807","https://openalex.org/W7133844073","https://openalex.org/W4396993189","https://openalex.org/W2520258735","https://openalex.org/W2900165601","https://openalex.org/W1890585248"],"abstract_inverted_index":{"Key":[0],"Points":[1],"Hyperkalemia":[2,40],"is":[3,20,41,51],"frequently":[4],"observed":[5],"in":[6,29,46,89,165,226,235,243,256,295,319],"patients":[7,30,47,199,210,255,300,320],"with":[8,31,48,53,91,200,206,264,301],"CKD,":[9,49,114,303,306,324],"and":[10,13,23,56,76,104,120,146,178,203,240,253,259,266,282,284,287,297,304,316],"its":[11],"frequency":[12],"severity":[14,179],"increase":[15],"as":[16],"CKD":[17,36,135,148,202,218,221,238,246,261],"progresses.":[18],"Patiromer":[19,309],"an":[21],"effective":[22,311],"well-tolerated":[24],"treatment":[25,86,99,313],"option":[26],"for":[27,84,251,312],"hyperkalemia":[28,88,115,315],"advanced":[32],"or":[33],"mild/":[34],"moderate":[35],"on":[37],"RAASi.":[38],"Background":[39],"a":[42],"common":[43],"electrolyte":[44],"abnormality":[45],"which":[50],"associated":[52],"worse":[54],"outcomes":[55],"limits":[57],"use":[58],"of":[59,69,78,87,101,113,180,299,314,323,326],"renin\u2013angiotensin\u2013aldosterone":[60],"system":[61],"inhibitors":[62],"(RAASi).":[63],"This":[64],"post":[65],"hoc":[66],"subgroup":[67],"analysis":[68],"three":[70],"clinical":[71],"trials":[72],"evaluated":[73],"the":[74,79,85,97,163,236,244,257],"efficacy":[75],"safety":[77],"sodium-free,":[80],"potassium-binding":[81],"polymer,":[82],"patiromer,":[83],"adults":[90],"nondialysis":[92],"CKD.":[93,208],"Methods":[94],"Data":[95],"from":[96,169],"4-week":[98],"periods":[100],"AMETHYST-DN,":[102],"OPAL-HK,":[103],"TOURMALINE":[105],"studies":[106],"were":[107,126,211,249,278,328],"combined.":[108],"Patients":[109,125],"had":[110],"baseline":[111,129,170,216],"diagnosis":[112],"(serum":[116],"potassium":[117,167,228],">5.0":[118],"mEq/L),":[119],"received":[121],"patiromer":[122,292],"8.4\u201333.6":[123],"g/day.":[124],"stratified":[127],"by":[128,162],"eGFR":[130,138,151],"into":[131],"two":[132],"subgroups:":[133],"severe/end-stage":[134,201,237,258,302],"(stage":[136,149],"3b\u20135;":[137],"<45":[139],"ml/min":[140,153],"per":[141,154],"1.73":[142,155],"m":[143,156],"2":[144,157],")":[145],"mild/moderate":[147,207,220,245,260,305],"1\u20133a;":[150],"\u226545":[152],").":[158],"Efficacy":[159,185],"was":[160,233,310],"assessed":[161],"change":[164,225],"serum":[166,227],"(mean\u00b1SE)":[168],"to":[171,230,272,291],"week":[172,231],"4.":[173],"Safety":[174],"assessments":[175],"included":[176,196],"incidence":[177],"adverse":[181],"events":[182],"(AEs).":[183],"Results":[184],"analyses":[186],"(":[187],"n":[188],"=626;":[189],"62%":[190],"male,":[191],"mean":[192],"age":[193],"66":[194],"years)":[195],"417":[197],"(67%)":[198],"209":[204],"(33%)":[205],"Most":[209],"receiving":[212,329],"RAASi":[213,331],"therapy":[214],"at":[215],"(severe/end-stage":[217],"92%;":[219],"98%).":[222],"The":[223,274],"mean\u00b1SE":[224],"(baseline":[229],"4)":[232],"\u22120.84\u00b10.03":[234],"subgroup,":[239],"\u22120.60\u00b10.04":[241],"mEq/L":[242],"subgroup.":[247],"AEs":[248,269,277,289],"reported":[250],"40%":[252],"27%":[254],"subgroups,":[262],"respectively,":[263],"16%":[265],"12%":[267],"reporting":[268],"considered":[270],"related":[271],"patiromer.":[273],"most":[275,325],"frequent":[276],"mild-to-moderate":[279],"constipation":[280],"(8%":[281],"3%)":[283],"diarrhea":[285],"(4%":[286],"2%).":[288],"leading":[290],"discontinuation":[293],"occurred":[294],"6%":[296],"2%":[298],"respectively.":[307],"Conclusions":[308],"well":[317],"tolerated":[318],"across":[321],"stages":[322],"whom":[327],"guideline-recommended":[330],"therapy.":[332]},"counts_by_year":[{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2022-08-03T00:00:00"}